BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14576937)

  • 1. Immunostaining for the tumour suppressor gene p16 product is a useful marker to differentiate melanoma metastasis from lymph-node nevus.
    Mihic-Probst D; Saremaslani P; Komminoth P; Heitz PU
    Virchows Arch; 2003 Dec; 443(6):745-51. PubMed ID: 14576937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity.
    Piana S; Tagliavini E; Ragazzi M; Zanelli M; Zalaudek I; Ciarrocchi A; Valli R
    Pathol Res Pract; 2015 May; 211(5):381-8. PubMed ID: 25661066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
    Lee JJ; Granter SR; Laga AC; Saavedra AP; Zhan Q; Guo W; Xu S; Murphy GF; Lian CG
    Mod Pathol; 2015 Feb; 28(2):218-29. PubMed ID: 25081754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.
    Mihic-Probst D; Mnich CD; Oberholzer PA; Seifert B; Sasse B; Moch H; Dummer R
    Int J Cancer; 2006 May; 118(9):2262-8. PubMed ID: 16331607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
    Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
    J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.
    Mentrikoski MJ; Ma L; Pryor JG; McMahon LA; Yang Q; Spaulding BO; Scott GA; Wang HL; Xu H
    Mod Pathol; 2009 Dec; 22(12):1582-7. PubMed ID: 19734845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
    Lezcano C; Pulitzer M; Moy AP; Hollmann TJ; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Apr; 44(4):503-508. PubMed ID: 31633488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes.
    Gambichler T; Scholl L; Stücker M; Bechara FG; Hoffmann K; Altmeyer P; Othlinghaus N
    Am J Clin Pathol; 2013 May; 139(5):566-73. PubMed ID: 23596107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevus cell aggregates massively occupying parenchyma of an external iliac lymph node: A case report and review of the literature.
    Hu J; Ren M; Cai X; Zhang Y; Lv JJ; Kong YY
    J Cutan Pathol; 2020 Dec; 47(12):1175-1180. PubMed ID: 32644206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal blue nevus: a pitfall in lymph node biopsies.
    Dohse L; Ferringer T
    J Cutan Pathol; 2010 Jan; 37(1):102-4. PubMed ID: 19615001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
    Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
    Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.
    Uguen A; Talagas M; Costa S; Duigou S; Bouvier S; De Braekeleer M; Marcorelles P
    Diagn Pathol; 2015 Oct; 10():195. PubMed ID: 26503349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.
    Hilliard NJ; Krahl D; Sellheyer K
    J Cutan Pathol; 2009 Jul; 36(7):753-9. PubMed ID: 19519606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph nodes in cutaneous melanoma.
    Prieto VG
    Clin Lab Med; 2011 Jun; 31(2):301-10. PubMed ID: 21549243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of p16 in Melanocytic Lesions: An Updated Review and Meta-analysis.
    Koh SS; Cassarino DS
    Arch Pathol Lab Med; 2018 Jul; 142(7):815-828. PubMed ID: 29939777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign nevus in lymph node.
    Gray GF; Dineen P
    N Y State J Med; 1976 May; 76(5):754-5. PubMed ID: 1063326
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.
    Dalton SR; Gerami P; Kolaitis NA; Charzan S; Werling R; LeBoit PE; Bastian BC
    Am J Surg Pathol; 2010 Feb; 34(2):231-7. PubMed ID: 20087158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.